Mesothelioma Missouri Law

Actos Bladder Cancer : As mentioned in the previous chapter, current practice is to blend chemotherapy drugs in order to get a head start in treating the can­cer before it becomes too extensive.The goal is increased effectiveness in fighting advanced bladder cancer. This practice has often resulted in a longer and more comfortable lifespan for many bladder-cancer patients and has made it possible to offer increased hope.

A quick review: Chemotherapy is a term that refers to drugs that fight cancer, usually by causing cancer cells to die or causing the process of their growth to stop. It is often a liquid medicine given by injection into the vein. Sometimes it can be administered as a tablet. Chemotherapy treatment is usually provided on an outpatient basis, although certain drugs, such as dsplatin, may be given during a short in-patient stay.

Chemotherapy treatments – which drugs are given and how often ~ vary from person to person, depending on the stage of disease, the patient’s age and overall health, and many other factors. Usually you will receive the drugs intravenously (by needle into the vein), and each treatment will take from one to several hours. You may receive several treatments over the course of a month, and treatments may be given for up to six months or occasionally a bit longer. (More infor­mation about chemotherapy is available in Chapter 5, including a detailed discussion of side effects and potential benefits.)

More information on Actos Bladder Cancer

Chemotherapy has many uses. It is given to reduce or eliminate cancer cells present in your body, as well as to prevent existing cancer cells from growing and flourishing. Chemotherapy can inhibit and sometimes prevent the formation of new cancer cells. It can shrink tumors so that they are safely operable. When chemotherapy is used to stop bladder cancer from coming back after treatment by cystecto­my or radiotherapy it is called adjuvant therapy. Chemotherapy is not yet able to cure all cancer, but it has certainly opened the door for many people to enjoy man)” months of extended life.

Again, a reminder: Chemotherapy is powerful medicine. In addition to causing damage to cancerous cells, it can damage cells in the bone marrow that produce blood.This means that your blood count may be lower than usual. A shortage of white blood cells can leave you vulner­able to infections. A low platelet count may lead to bruising or even extensive bleeding from minor cuts and scrapes. Low red blood cell counts leave you feeling fatigued or exhausted (a condition called anemia). These side effects usually go away after the treatment is stopped. Temporary symptoms such as nausea and vomiting can be controlled to some extent by drugs, while other, more permanent side effects can occur, such as infertility or premature menopause.

Information from other sources on Actos Bladder Cancer

The problem was that it was really quite toxic, with side effects that included nausea, vomiting, a sore mouth, risk of infection, and occasionally problems with cardiac (heart) function. Despite the problems, around 60 percent to 70 percent of patients experienced shrinkage of their metastatic bladder cancers in response to this treatment, and there were patients who survived in good health for several years after such treatment (without recurrence).

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : Radical cystectomy is one of the biggest and most complex procedures performed by urologists. In addition to its complexity from a technical standpoint, you will likely have many questions not only related to cancer control but also to quality of life after surgery. Cystectomy can affect your quality of life from both an emotional and physical standpoint. After surgery, you may face specific physical adjustments to die urinary diversion, possible changes in sexual function, and changes in bowel habits and function. Specific side effects and complications related to cystectomy and urinary diversion are discussed in Chapter 4. An essential aspect to enhanced quality of life after surgery is to be proactive in the decision-making process before surgery. Ask your surgeon many questions before surgery, because knowing what to expect after surgery will ease this transition. A cancer diagnosis is a difficult time for anyone, and thoughts and questions will race through your head faster than you can remember them. Write them down as you think of them, so you can have a complete discussion at the time of consultation with your physician.

As stated previously this is a big surgery, and your surgeon may have you see other specialists before your procedure to ensure you are in the best medical condition to undergo surgery. You may be admitted to the hospital the day before your scheduled surgery for any remaining tests and to prepare your bowel for surgery. In the last decade, however, medicine has become increasingly more outpatient based, and many surgeons have eliminated the preoperative admission and have you report to the hospital the morning of surgery. Your surgeon will most likely have you only consume clear liquid on the day before surgery to clear out your GI tract, which allows for a technically easier urinary diversion and may also decrease your risk of complications. Along this same line, most surgeons will have you do some form of bowel preparation the day or two leading up to surgery. This is also used to cleanse your GI tract before surgery.

Immediately after surgery you will generally stay in the hospital 5-10 days. Postoperative practice varies from surgeon to surgeon, but most leave a small drain in the abdomen to monitor for leakage of urine from the newly created diversion and intestinal contents from the reconnected bowel. If there is no evidence of an internal leak, the drain routinely is removed at the bedside (with minimal discomfort) before discharge from the hospital. Your surgeon may also leave a nasogastric tube in for the first day or so after surgery. This is a tube that goes from your nose to your stomach and keeps your stomach decompressed, which prevents abdominal bloating and vomiting.

More information on Actos Bladder Cancer

Generally, starting on the day after surgery you will be out of bed and with assistance from the hospital staff will start walking. It is very important to begin walking as soon as possible because it will make you feel better, will help with early return ofbowel function, and will decreasethe chances of developing blood clots in your legs and pelvic veins. You will also be instructed on breathing exercises while in bed and sitting to help expand your lungs after surgery and to prevent pneumonia. One of the major obstacles before discharge is return ofbowel function and resumption of a regular diet. Your GI tract can be slow to return to normal function, largely related to the bowel work required for the urinary diversion. This will take time, and it is important to not force your diet too soon after surgery because this will increase your chances of nausea and vomiting. In general, your body will tell you when you are ready to eat.

Use your time in the hospital to learn as much as you can about your urinary diversion. Most centers in which cystectomies are performed have an enterostomal therapist with expertise in taking care of patients with urinary diversions. If you have a new ileal conduit, they will go over the general maintenance of the abdominal stoma and urinary appliance bags. This will make you more comfortable and confident in dealing with your diversion at the time of discharge from the hospital. Upon discharge from the hospital, your surgeon will give you precise instructions regarding physical activity, exercise, and resumption of sexual intercourse. It is important to follow these instructions carefully to ensure a smooth postoperative recovery.

If you underwent a continent urinary diversion, you will likely be discharged from the hospital with a catheter in the newly created reservoir to temporarily drain the urine until the reservoir is completely healed. If you have a cutaneous catheterizable diversion, a catheter is left in the catheteriz- able channel and a separate catheter is often brought out through a separate incision in the abdominal wall. These are temporary and generally removed 2 to 3 weeks after surgery. If you have an orthotopic diversion, a Foley catheter is generally placed in the diversion through your urethra. It is extremely important that you are careful with these tubes at home because dislodgement requires replacement and occasionally can lead to damage of your newly constructed leservoir. Mucus is often secreted from the bowel used to create your new urinary reservoir, and the nurses in the hospital will teach you how to flush your tubes with sterile saline before discharge to avoid mucous obstruction, which can lead to inadequate drainage.

Information from other sources on Actos Bladder Cancer

Occasionally, a portion of the bladder involved with tumor can be removed while sparing the remainder of the bladder. In selected patients this allows for preservation of normal bladder function and continence and decreased complications because no urinary diversion is required. Unfortunately, only a small percentage of individuals will be candidates for such an approach—generally, patients with smaller, solitary tumors on the dome of the bladder. Individuals with multifocal tumors, large tumor, or carcinoma in situ are not candidates for this procedure. Recovery time for a partial cystectomy is generally quicker tiian that of a radical cystectomy, and hospital times tend to be shorter. A Foley catheter is left in place for 7-10 days to allow the bladder time to heal.

The basic function of the bladder is to store urine. By directly instilling medications into the bladder, physicians have capitalized on this property of the bladder. By placing these agents into the bladder, these agents come into direct contact with the cancer cells. Intravesical (within the bladder) therapy is often used for patients with non-muscle-invasive bladder cancer. It can be used immediately after TURBT, as a single dose, to prevent recurrence of noninvasive tumors and is also used in the form of weekly outpatient administrations (usually 6 weeks at a time) to prevent both the recurrence and progression of bladder cancer.

The two basic agents that are used as intravesical therapies are chemotherapy drugs and immunotherapy agents. The most commonly used therapy in the United States is bacillus Calmette-Guerin (B CG), which is a form of immunotherapy. BCG is actually a vaccine that was originally developed for protection from tuberculosis. In the 1970s and early 1980s, it was noted to have intravesical effectiveness for the treatment of non-muscle-invasive bladder cancer. Although the exact mechanism of BCG activity is unknown, it works through local stimulation of the immune system. A Foley catheter is placed in the bladder, and then BCG is administered through the catheter into the bladder for 1 to 2 hours. Traditionally, BCG has been given once a week for 6 weeks to patients with high-grade non-muscle- invasive bladder cancer or to those patients with carcinoma in situ. Some studies have shown that routine maintenance instillations in addition to die traditional 6-week course may be more effective in preventing disease recurrence. BCG has proven not only to prevent recurrence of bladder cancer, but also to prevent progression to muscle-invasive disease and therefore is the first-line intravesical agent used in the United States.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer(s) visit our site often.

http://www.seedol.com

Actos Bladder Cancer : There are currently many ongoing clinical trials in the field of bladder cancer that will hopefully improve not only the survival outcomes for patients with bladder cancer, but also the quality of life of those living with bladder cancer. Clinical trials are an extremely important aspect in the treat­ment of many medical illnesses. In fact, many treatments you undergo today, whether it is for bladder cancer or another medical condition, were likely at some point part of a clinical trial. Your physician may approach you regarding clinical trials that are ongoing at his or her institution or near you. Don’t interpret this to mean your condition is not treatable with the currently approved therapies; your physician may just happen to know of a trial that may be helpful to you.

There are many types of clinical trials; some deal with new medical or surgical treatments for bladder cancer, some with new imaging modalities for diagnosis and staging of bladder cancer, and some with the possible prevention of bladder cancer. If you are approached about a clinical trial it is important to know exactly what you are getting into before you enroll. Although there is generally a lengthy consent process, the best way to be informed is to ask questions of both your physician and the person running the trial.

More information on Actos Bladder Cancer

It is important to remember that any treatment for bladder cancer, both surgical and nonsurgical, may be associated with complications and side effects. Some side effects can be mild and self-limiting, whereas others can more signifkantiy impact your quality of life. The best way to plan for the side effects of treatment is to know about them ahead of time. Although this won’t prevent side effects or complications, prior knowledge and preparation may ease any difficulties during or after treatment. It is also important to remember that each individual is unique and responds to treatment differentiy. If you know somebody who has been treated for bladder cancer in the past and had a particularly good (or not so good) experience, this does not necessarily apply to your situation. In this chapter we discuss some of the more common side effects and
potential complications associated with the treatment of bladder cancer. The following discussion may seem overwhelming and a bit daunting, but its intent is not to cause you stress. For the most part, severe and significant complications with treatment are rare, but they do happen and you should consider your tolerance for such events when choosing the most appropriate treatment plan for you. The best preparation is knowledge; therefore being aware of potential side effects up front will allow you to make more informed treatment decisions.

Roughly 5-10 percent of patients experience a fever after a transurethral procedure. This is almost always due to a urinary tract infection. The most common symptoms of a urinary tract infection in this setting are fever, chills, side pain, and frequent or painftil urination. If you experience a fever postoperatively, you should contact your physician immediately. The vast majority of infections can be treated as an outpatient with oral antibiotics and resolve in several days. Most urologists give you antibiotics during your procedure and for a few days thereafter to prevent infection, but unfortunately a small percentage of patients will still experience an infection despite taking antibiotics. It is important to note that most patients have lower urinary tract symptoms after surgery. This is directly related to the manipulation from the cystoscope and any biopsies or resection that were performed. These procedures cause bladder and urethral inflammation, which may cause you to experience painful urination, urinary frequency, and urgency for several days after the procedure. These symp­toms are very similar to that of a urinary tract infection and can be confusing, but they do not cause fever like a urinary tract infection. If you are unsure whether your symptoms are a result of an infection or the procedure, the safest bet is to consult your urologist as soon as possible.

Urinary retention (inability to pass the urine) is another uncommon and generally self-limiting complication one can experience after surgery. In men, this is often caused by swelling of the prostate due to manipulation from the cystoscope. Excessive bleeding may also result in clot formation that can obstruct the flow of urine. Patients who experience this side effect urinate in small volumes or not at all, even though their bladder is uncomfortably full. The treatment for this is simple; a catheter is placed in your bladder for a few days to allow any edema (swelling) to resolve. The catheter can then be removed several days later and most patients void without difficulty at that point.

Information from other sources on Actos Bladder Cancer

At the time of TURBT, perforation of the bladder can occur. This happens if the full thickness of the bladder wall is resected at the time of TURBT. This is often inadvertent, but it can also be done intentionally by your surgeon in the case of a tumor that grows deep into the wall of the muscle. Most perforations are small and will close on their own, without additional intervention. You may need to have a Foley catheter for several days to permit healing and minimize leakage of urine from the perforation. In rare circumstances a bladder perforation may be so large or in such a location that it is dangerous to allow it to heal on its own. Such cases require open surgery to suture the bladder closed. This is performed through a lower midline incision. A Foley catheter again would be left in the bladder for several days to permit healing. Open surgery for bladder perforation is a rare event (less than 1 percent).

Radical cystectomy and associated urinary diversion is a complex procedure. Even in the best of hands, the potential for side effects and complications is significant. The most common side effects and complications related to this procedure are discussed below. Although this will give you a good understanding of what to expect after surgery, it is very important that you discuss the risks of cystectomy with your urologist before surgery to be as fully informed and prepared as possible.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : Cell growth is closely regulated by genes which are composed of DNA located in the command center of the cell, the nucleus. When the genes become defective, cell growth can become unregulated, and tumors can develop. Oncogenes, also called cancer genes, can be activated, resulting in uncontrolled cell growth. Other genes which help prevent abnormal cell growth called tumor suppressor genes may be inactivated. Genes can be activated which enhance the tumor cell’s ability to spread throughout the body. The body’s immune system is a critical safeguard against the formation of cancerous tumors, often destroying the abnormal cells before they have a chance to grow and divide.

Cancer cells can spread throughout the body. They can spread through the lymphatic system, composed of lymph channels and lymph nodes, or distantly to other organs or the skeleton via the blood stream (hematogenous spread). In the case of bladder cancer, the cells can also spread by being carried in the urine and implanting in other locations in the urinary tract.

Larger tumors are more likely to spread than smaller tumors. Another critical concern is the grade of the tumor. Normal cells are specialized, differentiated to perform specific function, and have a typical structural arrangement with surrounding cells. As cancers worsen, the cells become less specialized, less differentiated, and lose their normal structural arrangement, resulting in a higher pathologic grade.

More information on Actos Bladder Cancer

For bladder cancer, another key indicator for likelihood to spread is the depth of penetration into the bladder wall. The bladder wall is composed of an inner lining called the urothelium (made up of transitional cells) which rests on a membrane layer called the basement membrane, below which is the connective tissue layer (support tissues) called the lamina propria. Within the lamina propria lies a small amount of muscle called the muscularis mucosa. Deep to the lamina propria is the deep muscle of the bladder arranged in three layers. This layer is called the muscularis propria. Tumors located in the inside, superficial layers of the bladder wall are unlikely to spread. Tumors that grow into the deeper layers (down into the muscle of the bladder wall) are much more likely to spread. Furthermore, there is a definite link between the grade of the tumor and its likelihood of invasion. Low grade tumors are almost always noninvasive, while high grade tumors are usually invasive. In general, papillary tumors, which are delicate and frond like in appearance are usually low grade and superficial. This is to be contrasted to sessile tumors which appear solid, are often high grade and invasive. Depth of invasion is critical in establishing prognosis. The tumor which invades into the lamina propria is a far more serious tumor than the superficial tumor which demonstrates no invasion. It has a much higher propensity to progress to the muscle invasive tumor, a much more dangerous cancer, with a high risk for spreading beyond the bladder.

The pathologist studies the prepared slides and makes a determination of the grade of cancer. There are a number of criterions that are used: degree of cellularity, nuclear crowding, loss of polarity and differentiation, nuclear pleomorphism, chromatin pattern and mitotic activity. In layman’s terms, the pathologist looks at the size, shape and relationship of the cancer cells. The nucleus is often abnormal since it contains damaged or mutated DNA. Cancer cells look different than normal cells. The greater the difference from normal, the higher the grade will be. These parameters are utilized to reduce the subjective nature of pathology. In the end, the pathologist assigns a grade.

Information from other sources on Actos Bladder Cancer

The medical history of those with bladder cancer varies. For many patients, the first clue is blood in the urine, while in others, it may be an alteration in urination. Sometimes a tumor is found inadvertently on an X ray or ultrasound exam. In all cases, an initial assessment is implemented by the urologist. In this chapter, we will review the presenting findings of those with bladder cancer and how they are initially “worked up.”

A sign is a physical finding from an underlying disease or disorder which can be noted by the individual or the physician. A symptom is something the individual feels or experiences from a disease. A clinical sign is a physical finding, while a symptom is something the individual experiences.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer : The patient will be encouraged to do deep breathing exercises to prevent lung collapse. This process is generally assisted with a small device called a spirometer. If the individual has a history of lung disease or is congested post-operatively, respiratory treatments with inhaled medication may be instituted and provided by a respiratory therapist.

Pain post-op is initially treated often via the epidural catheter. Intravenous medication may be given as an alternative and switched to oral pain meds once the individual is tolerating liquids. Many physicians order a PCA (patient controlled anesthesia) in which the patient pushes a button that releases pain medication via an intravenous line into the blood stream. Maximal amounts of drug administered are carefully controlled by settings on the PCA to allow safe, effective analgesia.

During the post-op period, you will meet regularly with an enterostomy nurse who will teach you the mechanics of caring for an ostomy and handling the ostomy appliance. Gradually, your pain will diminish, strength will increase, and diet will be advanced. Drains placed intraoperatively to siphon off any excess fluids from the abdomen will be removed when no longer needed. Depending on the individual’s age, general health, the surgery itself, and whether any complications have occurred, discharge to home can be expected after approximately seven to ten days.

More information on Actos Bladder Cancer

For most patients in reasonably good health, few if any complications are the rule. A host of complications can occur with any major surgical procedure and hospital stay. The major complications associated with Radical Cystectomy include

Bowel injury: During difficult dissection, small intestines may be inadvertently opened. These injuries are usually immediately recognized and repaired without difficulty. During removal of the bladder, the rectum may be entered. Assuming the patient has had a complete bowel prep prior to surgery, the rectum is usually readily repaired.

Vascular injury: During removal of the pelvic lymph nodes, entry into a major vein or artery may result in significant blood loss. Smaller, inconsequential veins or branches into larger veins are usually ligated with a suture or cauterized shut. Larger veins and arteries require repair with a fine vascular suture and needle. Troublesome bleeding can also occur during removal of the bladder and from deep in the pelvis after the bladder and prostate are removed. Bleeding is stopped through suture ligation, vascular clips, or cautery.

Abscess: An abscess is a pocket of pus located deep within the body. It may form from a bowel or urine leak, and generally will require drainage since antibiotics alone may not resolve it. If percutaneous drainage (drainage through the skin) is possible, the radiologist will drain the abscess. If this is not possible, the urologist will need to open the incision or make a new incision to allow the pus to be drained. A sizable abscess will generally not be cured without proper drainage. Left untreated, an abscess can result in sepsis, a life threatening bacterial infection.

Information from other sources on Actos Bladder Cancer

Bowel leak: When the bowel is reconnected after removing the section for the urinary diversion, healing may not be adequate and bowel contents may leak into the abdomen. A bowel leak often will present as a failure of the bowel to return to normal function, resulting in a distended abdomen with poor bowel sounds. Distention, ileus (poor bowel function) may occur after the bowels are working well and feeding has been going on for some time. Evaluation is usually accomplished with CT Scan and oral contrast. Immediate surgical correction may be necessary. Left untreated, a bowel leak will generally lead to an abscess or possibly a fistula (a drainage tract from the bowel which may extend out through the incision or drain). The incidence of bowel leak is increased if bowel has been exposed to prior radiation, most often from radiation used to treat prostate cancer in men and uterine cancer in women.

Bowel obstruction: When a piece of bowel is separated from the intestine to create the new urinary drainage system, the remaining bowel must be reanastomosed (brought back together). This may be accomplished via sewing the bowel together or through the use of staples. Sometimes the opening of the bowel connection may be obstructed secondary to swelling. If an obstruction does not clear after a reasonable time, reoperation may be required.

Erectile dysfunction: During a standard radical cystectomy in the male, the fine nerves which run along the base of the prostate to the penis are severed, resulting in loss of erections (impotence). If the individual having surgery still has good erections and is sexually active, these nerves can be attempted to be saved by modifying the surgery. Saving the nerves is more difficult to do, it takes more time, and is not always successful.

Female sexual dysfunction: In the female patient at the minimum, the section of the vagina contiguous to the bladder is removed. In the presence of extensive bladder cancer, more of the vagina may need to be removed. Narrowing and shortening of the vagina may result, making sexual intercourse difficult, painful, or impossible. The vagina is reconstructed intraoperatively so that sexual relations can continue. For those requiring major removal of the vagina, future reconstruction of the vagina by additional surgery can be accomplished once the individual has fully recovered and is free of cancer.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer :  While still awake, you will be transferred onto the operating room table and secured on it. If an epidural has not already been placed, one may be inserted. You may have an additional intravenous line placed. Next, your anesthesiologist will have you breathe through a mask placed over your nose and mouth. You will be given a mixture of agents which will allow you to become relaxed. Further anesthetics will result in an unconscious state. At this time, an endotracheal tube will be passed down your windpipe to provide oxygen, which is delivered automatically by a respirator, controlled by the anesthesiologist. The anesthesiologist will continuously monitor your heart rate, blood pressure, electrocardiogram, and tissue oxygenation throughout your operation.

Fluid balance may also be measured via an intravenous line passed close to your heart. Urine output will be followed. Antibiotics will be infused intravenously. Usually, compression stockings will be secured around your legs. These stockings periodically squeeze the legs to prevent blood from becoming stagnant, lowering the risk of blood clots forming in your legs, which can occur when you lie completely motionless for extended periods of time. A nasogastric tube will be passed through your nostril down your esophagus into the stomach, draining the stomach secretions during and after the surgery. A grounding pad will be placed on your side to allow for the safe use of electric current which is used to sometimes cut tissue and often in the cauterization of small bleeding vessels to stop bleeding.

Your abdomen will be prepared for surgery by shaving any hair and prepping the skin with an antiseptic solution. Female patients will have the vagina prepped with antiseptics as well. The surgical field will then be draped with sterile towels and sheets to prevent contamination from surrounding non-sterilized areas. Your upper body may be kept warm with a warming blanket. Your surgical nurse, surgeon, and assistant will all have thoroughly cleaned their hands and arms (scrubbed) and will then don a sterile gown and gloves. Their hair will be covered with a surgical cap, and they will be wearing masks over their mouths to prevent any contamination of the sterilized surgical field.

The standard operation is called Radical Cystectomy. This operation is accomplished through an incision which extends down the middle of the abdomen beginning at the level of the umbilicus and extending down to the pubic bone. The peritoneum (the sac around your intestines) is opened. The surgeon will examine the abdomen to make sure there is no evidence of cancer spread. Removal of the lymph nodes from the pelvis around the bladder is accomplished. The bladder is removed in its entirety along with the prostate and seminal vesicles in the male. In the female, the uterus and vagina are adjacent to the bladder and may be involved with local spread of cancer beyond the bladder. Consequently, the uterus and part of the vagina are removed. Since most females having a cystectomy are well past menopause, the ovaries are also removed, thus avoiding the possibility of future diseases including ovarian cancer.

More information on Actos Bladder Cancer

Once the bladder and surrounding organs are removed, the urinary tract must be reconstructed. This is most often accomplished by sewing the ends of the ureters into a piece of ileum (a section of small intestine) which is brought out through the skin as an ostomy. This form of reconstruction is called an ileal loop diversion. Since this reconstruction involves the urinary tract, the ostomy is referred to as a urostomy. Prior to sewing the ureters into the ileum, a biopsy of the ends of both ureters is examined by a pathologist to make sure there is no carcinoma in situ present. If cancer is found at the end of the ureter, this section is removed and the next higher level is examined by the pathologist to assure the ureter is free of cancer at the implantation site. If a neobladder is being planned, the prostatic urethra is examined by the pathologist to assure no cancer is present prior to proceeding further.

Transitional cell cancer extending into the urethra of a female patient or the prostatic urethra of a male patient would generally require urethrectomy at the time of cystectomy. Urethrectomy requires more dissection, potential for bleeding and infection, and possibly increased post operative drainage. It should therefore be performed only when necessary. Cancer located close to the bladder neck may raise the odds of cancer developing in a urethra which is left behind. The status of the urethra can be followed post cystectomy with washings sent for cytology. If cancer subsequently develops, a urethrectomy can be accomplished as a separate operation long after cystectomy has been done.

Information from other sources on Actos Bladder Cancer

At the conclusion of surgery, generally while still in the operating room, the endotracheal tube is removed when the patient is awake enough to breathe on his own. The patient will then be brought to the recovery room where he will be carefully observed by trained nurses in conjunction with the anesthesiologist and urologist. The individual is kept in the recovery room until conscious, breathing on his own and stable. Recovery room stays may be short, on the order of 30 minutes, or may extend to several hours, depending on how the individual is doing. If doing well, the patient will then be transferred to a floor in the hospital. If the individual’s surgery was particularly complicated, extended, or if the individual is unstable (irregular heart beat, low blood pressure, inability to be taken off the respirator), or if the individual has significant medical problems or has experienced a complication from surgery, transfer to an ICU (intensive care unit) may be warranted. In the ICU, there exists a much higher ratio of nurses to patients than on a standard postoperative floor, allowing for constant surveillance and care for critical patients. Also, if a respirator is required postoperatively, initial treatment in an ICU is usually necessary.

After transfer to the floor from the recovery room, the patient is often kept on bed rest for the rest of the day. The nasogastric tube is left in and placed to gentle suction to remove excess stomach fluids. Initially, nothing is allowed by mouth other than ice chips or sips of water. Adequate fluids and some nutrition are given via an intravenous catheter. By the following day, patients are often out of bed and sometimes walking with assistance. Sequential stockings on the lower legs are removed while ambulating, and discontinued once the individual is able to move about well. Traditionally, nasogastric tubes have been left in until the bowel activity returns (generally 3-4 days). This is generally heralded by the passing of flatus (gas) or the presence of active bowel sounds, which will be checked by your urologist with a stethoscope. Recent studies have indicated nasogastric drainage for this length of time may not be necessary and may impede normal breathing, leading to other problems. Some urologists are therefore removing the tubes earlier. Feeding is gradually introduced however, once bowel activity has returned.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Bladder Cancer :

Some tumors, including carcinoma in situ (CIS) tumors, are considered a high-grade bladder cancer because they characteristically have a high rate of progression to muscle- invasive tumors and also because they don’t have any differentiated features. The paradox is that they are only one cell thick, which usually correlates with lack of invasion. About 50 percent of the people diagnosed with CIS who have no other types of tumor present in the bladder will eventually have the CIS invade the muscle.

Recently, an extensive body of research work has suggested that abnormalities (known as “mutations”) of the genes that control the growth of bladder cancer may be important in helping to determine the prognosis of bladder cancer. While this is not yet routinely applied to clinical practice, preliminary studies have suggested that mutation of such genes as the P53 gene may be associated with more aggressive behavior of the tumor, with a greater tendency to spread. The P53 gene, which is part of the genetic makeup of the tumor, normally acts to suppress tumor growth; in some cancers, when an abnormality or mutation occurs, that tumor suppressive role is lost.

More information on Actos Bladder Cancer

Other genes may also be involved in this process, including those known as the Rb gene, Pi6 gene, and a gene that controls the epidermal growth factor receptor (EGFR). As this book is being written, a major clinical trial is studying whether these preliminary observations are true, and the final results are not known. We mention this to encourage you to discuss with your own physician the current state of the art of measuring genes and comparing the results with the outcomes of treatment of bladder cancer.

Information from other sources on Actos Bladder Cancer

Physicians and researchers can draw some general conclusions about bladder cancer and its diagnosis and treatment, but it is not always easy to predict how it will behave in a given individual.

Your physician and oncologist work with the pathologist to get an idea of your likely prognosis that is a5 accurate as possible, but the reality is that tumors of the same type don t always develop or progress in the same way. Nor do vthey always respond to treatment in the same way, and they don’t always follow a predictable pattern of recurrence.

Generally, one can say that the more deeply into the bladder layers cancer has spread, the more likely it is to recur. But some superficial cancers become invasive. And some don’t. Doctors and researchers don’t yet have all the key indicators to predict which superficial cancers will become invasive and recur and which ones wont.

In general, if you have been diagnosed with superficial urothelial cancer, you can expect a 40 percent chance that the cancer won’t recur, especially if you have a low-grade tumor where the cancer cells closely resemble normal bladder cells.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

http://www.seedol.com

Actos Lawyer 12/21/2011: The urethra is a hollow tube lined with transitional cells at its beginning that connects the bladder to the outside world. The structure of the urethra is different in men and women. The urethra is short in women and is much longer in men due to the presence of the penis. The cells lining the urethra change along its length. The inner cells, closest to the bladder, are transitional cells, whereas the cells closest to the outside of the body are squamous cells resembling skin. Although the urethra has different lengths in men and women, it functions the same. In men, the urethra passes through the prostate gland near the bladder.

Foe more information on Actos Lawyer follow us on our RSS Feeds.

Our use of the Terms Actos Bladder Cancer, Actos Attorneys is not intended to imply or insinuate that there is any relationship or connection between Best Legal Source and the maker of Acts. Actos is a trademark of its manufacturer, Takeda Pharmaceutical Company Limited. Best Legal Source is not the maker of Actos nor do we have any connection with Takeda Pharmaceutical Company Limited.

http://www.seedol.com

Actos Lawyers12/20/2011: There are multiple factors which must be considered. Generally younger patients, those in better overall health, and those with excellent preoperative erections can expect a more rapid return of erectile activity if the nerve sparing approach is successful. Even with meticulous nerve sparing, some nerve injury, either temporary or permanent may occur. The extent of the injury will determine how quickly erections may return. Erections may start returning in as little as two to three months, or may gradually return over a period of a year, or may not return at all.

For more information on Actos Lawyer follow us on our RSS Feeds.

Our use of the Terms Actos Lawsuit, Actos Bladder Cancer is not intended to imply or insinuate that there is any relationship or connection between Best Legal Source and the maker of Actos. Actos is a trademark of its manufacturer, Takeda Pharmaceutical Company Limited. Best Legal Source is not the maker of Actos nor do we have any connection with Takeda Pharmaceutical Company Limited.

http://www.seedol.com